Midori A. Yenari
San Francisco VA Medical Center
193 Papers
2.4K Citations
Midori A. Yenari is an academic researcher from San Francisco VA Medical Center. The author has contributed to research in topics: Medicine & Neuroprotection. The author has an hindex of 72, co-authored 185 publications. Previous affiliations of Midori A. Yenari include Veterans Health Administration & United States Department of Veterans Affairs.
Chat about Author
Papers
Mild hypothermia inhibits inflammation after experimental stroke and brain inflammation.
TL;DR: Mild hypothermia decreases inflammatory responses in both brain inflammation and stroke, implicating a direct anti-inflammatory effect of cooling, which suggests that hypthermia can attenuate factors contributing to delayed ischemic injury.
Collateral Flow: Prolonging the Ischemic Penumbra
TL;DR: Experts in various aspects of the cerebral collateral circulation are brought together to write authoritative reviews summarizing the scientific knowledge in these domains, focusing on how this system contributes to the Evolving Ischemic Penumbra.
Neuroprotection: heat shock proteins.
Stephen Kelly,Midori A. Yenari +1 more
TL;DR: This chapter highlights the involvement of H SP70 involvement in the pathophysiology of cerebral ischaemia, from the original reports of HSP70 expression after cerebral iscaemia to evidence of Hsp70 neuroprotection and the potential mechanisms which might mediate this cellular protection.
Plasma Lipoprotein-associated Phospholipase A2 and Superoxide Dismutase are Independent Predicators of Cognitive Impairment in Cerebral Small Vessel Disease Patients: Diagnosis and Assessment
Shuzhen Zhu,Xiaobo Wei,Xiaohua Yang,Zifeng Huang,Zihan Chang,Fen Xie,Qin Yang,Changhai Ding,Wei Xiang,Hongjun Yang,Ying Xia,Zhong-Ping Feng,Hong-Shuo Sun,Midori A. Yenari,Lin Shi,Vincent Mok,Qing Wang +16 more
TL;DR: Lp-PLA2 and SOD are independently associated with cognitive impairment and WMH lesion, and may be useful for the rapid evaluation of cognitive impairment in CSVD.
Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses
Junqiang Yan,Yunqi Xu,Cansheng Zhu,Limin Zhang,Aimin Wu,Yu Rong Yang,Zhaojun Xiong,Chao Deng,Xu-Feng Huang,Midori A. Yenari,Yuan-Guo Yang,Weihai Ying,Qing Wang,Qing Wang +13 more
TL;DR: Results provide strong evidence that NMDA receptor modulation after simvastatin treatment could partially explain its anxiolytic-like activity and anti-inflammatory mechanisms in experimental parkinsonian models.